Medicamen Organics Ltd
Incorporated in 1995, Medicamen Organics Limited develops pharmaceutical dosages including generic doses in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders.[1]
- Market Cap ₹ 106 Cr.
- Current Price ₹ 90.7
- High / Low ₹ 159 / 90.0
- Stock P/E 44.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 16.6 %
- ROE 19.9 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 12.4% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 241 days.
- Working capital days have increased from 179 days to 252 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| 25.05 | 20.98 | 22.15 | 25.27 | |
| 23.41 | 19.78 | 20.29 | 20.53 | |
| Operating Profit | 1.64 | 1.20 | 1.86 | 4.74 |
| OPM % | 6.55% | 5.72% | 8.40% | 18.76% |
| 0.01 | 0.21 | 0.82 | 0.02 | |
| Interest | 0.48 | 0.47 | 0.61 | 0.65 |
| Depreciation | 0.68 | 0.68 | 0.71 | 0.72 |
| Profit before tax | 0.49 | 0.26 | 1.36 | 3.39 |
| Tax % | 40.82% | 61.54% | 28.68% | 28.91% |
| 0.30 | 0.09 | 0.97 | 2.40 | |
| EPS in Rs | 0.50 | 0.15 | 1.62 | 2.79 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 0% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 100% |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 20% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 8.60 |
| Reserves | 1.47 | 1.56 | 2.98 | 6.58 |
| 9.59 | 10.24 | 11.79 | 12.66 | |
| 9.28 | 9.27 | 11.82 | 10.75 | |
| Total Liabilities | 26.34 | 27.07 | 32.59 | 38.59 |
| 11.35 | 11.29 | 10.87 | 10.35 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.15 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| 14.99 | 15.78 | 21.72 | 28.09 | |
| Total Assets | 26.34 | 27.07 | 32.59 | 38.59 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -1.16 | 0.04 | -0.58 | -3.69 | |
| -0.02 | -0.59 | -0.28 | -0.33 | |
| 1.27 | 0.18 | 0.94 | 4.01 | |
| Net Cash Flow | 0.09 | -0.37 | 0.07 | -0.01 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 109.72 | 108.73 | 177.47 | 241.21 |
| Inventory Days | 61.22 | 128.47 | 225.01 | 244.39 |
| Days Payable | 161.56 | 198.97 | 329.82 | 281.81 |
| Cash Conversion Cycle | 9.38 | 38.24 | 72.66 | 203.80 |
| Working Capital Days | 83.35 | 121.61 | 163.30 | 251.61 |
| ROCE % | 4.19% | 10.22% | 16.62% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
18 July 2024 - Medicamen Organics Limited has informed about Certificate under Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 July 2024 - Medicamen Organics Limited has informed about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2024
-
Updates
15 July 2024 - Medicamen Organics Limited has informed regarding 'Non-applicability Certificate for Corporate Governance pursuant to Regulation 27(2) as per SEBI (LODR) Regulations, 2015 for the quarter ended …
-
Updates
15 July 2024 - Medicamen Organics Limited has informed regarding 'Medicamen Organics Limited expands its overseas operations by signing MoU with Depot Pharmacy Yego Limited in Rwanda'.
Annual reports
No data available.
Product Portfolio[1] Their product list comprises 84 products with a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).